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Syntheses of polypyridyl metal complexes and
studies of their interaction with quadruplex DNA†
Verity S. Staﬀord,a Kogularamanan Suntharalingam,‡a Arun Shivalingam,a
Andrew J. P. White,a David J. Mannb and Ramon Vilar*a
A series of mono- and bi-metallic metal complexes (with CuII, PtII and ZnII) with substituted polypyridyl
ligands have been prepared and their binding aﬃnities towards quadruplex (c-Myc and human telomeric)
and duplex DNA (ds26 and calf thymus) determined using ﬂuorescent indicator displacement (FID) assays
and UV/vis spectroscopic titrations. These studies have shown that the number of aromatic rings and
number/position of cyclic amine substituents on the ligands, play an important role in deﬁning the DNA
binding abilities of the resulting metal complexes. We also show that bi-metallic complexes prepared
using a novel terpyridine-cyclen ligand have higher aﬃnity towards G-quadruplex DNA as compared to
their mono-metallic counterparts. Cytotoxicity assays were carried out for all the new complexes against
an osteosarcoma cancer cell line (U2OS) as well as a normal ﬁbroblast cell line (GM05757). Several of
these compounds displayed cytotoxicity similar to that of cisplatin.
Introduction
Guanine-rich oligonucleotides have the ability to self-assemble
into quadruply-stranded structures known as G-quadruplexes.1
As has been extensively discussed in the recent literature, the
formation of G-quadruplex DNA in vivo has been associated
with a number of important biological processes including
regulation of gene expression and telomere maintenance.2,3
Due to their proposed biological relevance, G-quadruplexes are
attractive targets for anticancer drugs.4–7 Therefore, there has
been increasing interest in the development of small mole-
cules able to interact with high aﬃnity and selectivity with
quadruplexes. While initially most quadruplex binders were
based on purely organic planar molecules,8–10 more recently
an increasing number of metal complexes have been shown to
be excellent quadruplex binders.11
Over the past ten years we have developed several families
of platinum(II) square planar complexes aimed at interacting
with quadruplex DNA structures. The design of these platinum
(II) complexes is based around planar polyaromatic ligand
frameworks such as salphen,12 phenanthroline,13,14 disubsti-
tuted pyridines15 and terpyridines.16–18 In these examples, the
metal plays an important structural role organising the poly-
aromatic ligands in an optimal planar geometry for end-stack-
ing on top of guanine tetrads (via π–π interactions). In
addition to their structural features, the metal ions withdraw
electron density from the corresponding ligand framework
which in turn renders the aromatic rings more prone to dis-
playing π–π stacking interactions.11 Another important design
feature when developing quadruplex binders is the addition of
basic substituents to the planar π–π stacking core, which can
be protonated at physiological pH. These groups have been
shown to increase the solubility of the compounds in aqueous
media as well as enhancing their interactions with quadru-
plexes. While most substituents used so far are based on
organic groups (e.g. amines, amino acids) we recently incorpor-
ated as part of our design a “side-arm” based on a metal
complex.16 The resulting di-metal complexes displayed higher
aﬃnities towards quadruplex DNA in comparison to the
corresponding mono-metallic complexes.
The first studies of metal-terpyridines as G-quadruplex
binders were reported by Teulade-Fichou et al.19–21 These
studies showed that square planar and square-based pyramidal
metal complexes containing substituted terpyridines, are very
good G-quadruplex binders. Subsequently, we synthesised a
diﬀerent family of terpyridine metal complexes (1–4, see
Fig. 1) and also showed that the platinum(II) square planar
complexes had good aﬃnity for G-quadruplexes.17 Ligands
based on phenanthroline have also been previously used to
prepare metal complexes with high aﬃnity towards
quadruplexes.13–15,22–29
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We have now extended our studies on polypyridyl metal
complexes and present our results herein. More specifically,
we have synthesised two new ligands (L4 and L8) and ten
new mono- and bi-metallic metal complexes (5–15). The
aﬃnity of the new complexes towards G-quadruplex (c-Myc and
HTelo) and duplex (d26 and calf thymus) DNA has been deter-
mined by fluorescent indicator displacement (FID)30,31 assays
and UV/vis spectroscopic titrations. In addition, we report the
cytotoxicity of these complexes against the osteosarcoma
cancer cell line U2OS as well as against the normal fibroblast
cell line GM05757.
Results and discussion
Synthesis of substituted polypyridyl ligands
The ligands and complexes studied in this work are shown in
Schemes 1 and 2 and Fig. 2–4. The rationale behind these
ligands and the corresponding complexes was to explore the
eﬀect of various parameters on G-quadruplex binding. In par-
ticular, we focussed upon the eﬀects of increasing the number
of aromatic rings (e.g. comparing 15 with 3 and 4) and exchan-
ging the labile chloride coordinated to the platinum(II) metal
centre with a thiolate (complexes 5–7 and 14); we were also
interested in studying the impact of a second metal centre
within the same molecule (e.g. 11 and 12) on the aﬃnity of the
complexes toward G-quadruplex DNA.
Ligands L2 and L3 were prepared as previously reported,17
while L4 was prepared by reacting the tri-Boc protected cyclen
(Cyc-Tri-BOC),32 with 2,6-bis(2-pyridyl) 4(1H) pyridone (see
Scheme 1) to first yield L4-BOC. This intermediate product was
treated with TFA in CH2Cl2 to remove the BOC protecting
groups. To neutralise the protonated crude solid, it was first
dissolved in water and aqueous NaOH (2 M) was added drop-
wise until the solution became alkaline (pH 12). The product
was then extracted into CH2Cl2. The solvent was removed
under reduced pressure to yield L4 as a pale yellow sticky solid.
This terpyridine-cyclen ligand was fully characterised by 1H
and 13C NMR spectroscopy (including 1H–1H COSY NMR – see
Fig. S1 in the ESI†), as well as by mass spectrometry (m/z =
462 a.m.u., [M + H]+).
Ligand L6 was prepared by coupling phenanthroline and
2-bromopyridine as shown in Scheme 2. The compound was
fully characterized by 1H NMR spectroscopy as well as by mass
spectrometry (m/z = 253 a.m.u., [M + H]+) and its purity con-
firmed by elemental analyses. The mono-functionalized
pyridyl-phenanthroline ligand, L8, was prepared using a two-
step approach: 5-chloro-1,10-phenanthroline was reacted with
1-(2-hydroxyethyl)piperidine and KOH in degassed DMSO to
yield L7 (Scheme 2). The substituted phenanthroline was then
coupled with 2-bromopyridine using nBuLi as a base. Upon
extraction into CH2Cl2, re-oxidation using MnO4 and purifi-
cation via alumina column chromatography, the desired
product was isolated. The ligand was characterised by 1H NMR
spectroscopy where the resonances of the aromatic protons
were observed to shift downfield relative to the starting
material. Furthermore, formation of the desired C–C bond was
clearly shown by the disappearance of one ortho-phenanthro-
line proton signal. A distinctive molecular ion peak was
observed in the ESI mass spectrum (m/z = 407 a.m.u.,
[M + Na]+), providing further evidence for product formation.
Fig. 1 Metal-terpyridine complexes with M = ZnII, CuII and PtII pre-
viously reported and studied as G-quadruplexe binders.
Scheme 1 Reaction scheme for the syntheses of ligand L4.
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Synthesis of metal complexes
The new thiolato platinum complexes 5–7 were prepared by
reacting the corresponding platinum(II)-terpyridine-chloro
derivatives, [Pt(terpy)Cl]Cl, 3 and 4, with 4 equivalents of L5
(which was prepared by modification of a reported pro-
cedure33) in water at 25 °C for 48 h. Upon completion of the
reactions, excess thiol starting material was removed. Complex
5 (as the chloride salt [Pt(L1)(L5)]Cl) was isolated as a deep
purple solid. In contrast, complexes 6 and 7 could not be iso-
lated pure as the chloride salts. In these cases an additional
counter-anion exchange step was required, so the chloride ion
was exchanged for PF6
− ion to yield [Pt(L3)(L5)](PF6) (6) and
[Pt(L4)(L5)](PF6) (7) as orange solids.
The platinum(II)-thiol complexes were fully characterised by
1H NMR (and 31P NMR in the case of 6 and 7) spectroscopy,
UV-Vis spectroscopy, mass spectrometry and elemental ana-
lyses. The aromatic proton signals were observed to shift
Scheme 2 Reaction schemes for the syntheses of ligand L6–L8.
Fig. 3 Chemical structures of the platinum(II)-thiolate complexes 5–7.
The counterion for complex 5 is Cl−, while for 6 and 7 is PF6
−.
Fig. 2 Chemical structures of the terpyridine ligands employed to prepare the corresponding metal complexes under investigation.
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downfield (ranging from 0.2 to 0.8 ppm) relative to the corres-
ponding platinum(II)-chloro complexes, clearly demonstrating
coordination of the thiol arm to the fourth position of the
platinum(II)-terpyridine motif. The largest shift was observed
for the ortho-terpyridine peak (0.8 ppm downfield), likely to
result from the magnetic anisotropy of the neighbouring plati-
num–sulfur bond. The appearance of a LMCT/ILCT band
(charge transfer from the sulfur p orbital to the platinum/
terpyridine orbitals) at 505 nm in the UV-vis spectrum pro-
vided further evidence for the successful coordination of
the thiol ligand. Complex 5 was also characterised by X-ray
crystallography (see below).
The dinuclear complexes 8 and 9 were prepared by reacting
L4 (in methanol) with a methanolic solution containing 2
equivalents of the appropriate metal chloride salt (ZnCl2 and
CuCl2·2H2O respectively). These solutions were heated at 40 °C
for 48h after which time white and blue precipitates were
obtained for the zinc(II) (8) and copper(II) (9) complexes
respectively. These solids were purified by recrystallization:
acetone was allowed to slowly diﬀuse into concentrated
aqueous solutions of the complexes over 7 days yielding crys-
tals of 8 and 9 suitable for X-ray crystallographic analysis (see
below). These crystalline solids were also characterised by
mass spectrometry and elemental analyses. The di-zinc(II)
complex 8 was further characterised by 1H and 13C NMR
spectroscopy (including 1H–1H COSY NMR – see Fig. S2 in the
ESI†).
Complex 10 was prepared by reacting L4 with K2PtCl4 in
DMSO for 24h. Addition of acetone to the reaction mixture
yielded an orange solid (the chloride salt of 10) which was sub-
sequently redissolved in DMSO and treated with an aqueous
solution of NaPF6 to precipitate 10 as the pure PF6
− salt. This
complex was characterised by 1H and 13C NMR spectroscopy,
mass spectrometry and elemental analyses. The hetero-bi-
metallic complexes 11 and 12 were prepared by reacting 10
with the corresponding metal salt (ZnCl2 and CuCl2·2H2O
respectively) in DMSO. Addition of aqueous NaPF6 to this solu-
tion yielded the corresponding Pt–Zn and Pt–Cu complexes as
yellow and green solids respectively. Both complexes were
characterised spectroscopically and by elemental analyses.
The two phenanthroline-based ligands L6 and L8 were
reacted with [Pt(COD)Cl2] in water at 75 °C for 3 h to yield the
corresponding platinum(II) complexes 13 and 15 (isolated as
the Cl− and PF6
− salts respectively). Complex 13 (which has
been previously reported34) was then reacted with thiol L5 in
water to yield the new complex 14 (Fig. 5). These three plati-
num complexes were fully characterised by 1H NMR spec-
troscopy, mass spectrometry and elemental analyses.
Fig. 4 Chemical structures of the zinc(II), copper(II) and platinum(II)-terpy-cyclen mono- and di-metallic complexes 8–12. The counterion for
complex 8 is 1/2[ZnCl4]
2−, for 9 is Cl− and for 10–12 PF6
−.
Fig. 5 Chemical structures of the platinum(II)-phenanthroline complexes 13–15. The counterion for complex 13 is Cl−, while for 14 and 15 is PF6
−.
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X-ray crystal structures of compounds 5, 8 and 9
Crystals of 5 suitable for an X-ray crystallographic study were
grown by slow diﬀusion of diethyl ether into a methanolic
solution of the compound. The platinum centre in the struc-
ture of this complex (Fig. 6) was found to have adopted a dis-
torted square planar coordination geometry, the Pt, N(1), N(8),
N(14) and S(19) atoms being coplanar to within ca. 0.01 Å.
This planarity extends to include the terpyridine unit, the
twenty non-hydrogen atoms being coplanar to within
ca. 0.08 Å. This extended planarity allows the cations in 5 to
pack across two independent centres of symmetry to form an
extended stack along the crystallographic a axis direction
(Fig. 7). The N(1)-based ring in one cation links to its counter-
part in an adjacent Ci-related cation (centroid⋯centroid and
mean interplanar separations of ca. 3.68 and 3.41 Å, rings paral-
lel, interaction a in Fig. 7), whilst the N(8)- and N(14)-based
rings are linked across an independent centre of symmetry (cen-
troid⋯centroid and mean interplanar separations of ca. 3.81
and 3.40 Å, rings inclined by ca. 4°, interaction b in Fig. 7).
The structure of the di-zinc complex 8 (crystals of which
were grown by slow diﬀusion of acetone into concentrated
aqueous solution of the complex) was found to contain two
independent cations (8-A and 8-B) with noticeably diﬀerent
coordination geometries between the terpyridine unit and the
ZnCl2 moiety (cation 8-A is shown in Fig. 8, whilst cation 8-B is
shown in Fig. S6 in the ESI†). For cation 8-B the terpyridine
unit is approximately planar, and this plane includes the
metal atom with Zn(1B) lying only ca. 0.02 Å out of the N3
plane (the torsion angles between the N(1B)- and N(8B)-based
rings, and between the N(1B)- and N(14B)-based rings being
ca. 3 and 1° respectively). This results in a distorted trigonal
bipyramidal coordination geometry at Zn(1B) with a signifi-
cantly bent major axis [N(8B)–Zn(1B)–N(14B) 150.33(9)°,
Table 1]. Cation 8-A has a noticeably diﬀerent geometry at
Zn(1A) with the metal slightly perching above the N3 plane by
ca. 0.32 Å. This perching distorts the terpyridine unit away
from planarity, the torsion angles between the N(1A)- and
N(8A)-based rings, and between the N(1A)- and N(14A)-based
rings being ca. 13 and 2° respectively, resulting in a coordi-
nation geometry best described as distorted square-based
Fig. 6 The structure of the di-cationic complex present in the crystal of
5. Selected bond lengths (Å) and angles (°); Pt–N(1) 1.972(3), Pt–N(8)
2.026(4), Pt–N(14) 2.044(4), Pt–S(19) 2.3131(10), N(1)–Pt–N(8) 80.69(14),
N(1)–Pt–N(14) 80.60(15), N(1)–Pt–S(19) 178.78(10), N(8)–Pt–N(14)
161.29(15), N(8)–Pt–S(19) 98.57(11), N(14)–Pt–S(19) 100.13(11).
Fig. 7 Part of one of the π–π linked stacks of cations along the a-axis
direction present in the crystal of 5. The π–π stacking interactions have
centroid⋯centroid and mean interplanar separations (Å) of (a) 3.69, 3.35,
and (b) 3.80, 3.40 respectively.
Fig. 8 The structure of one (8-A) of the two independent cationic com-
plexes present in the crystal of 8.
Paper Dalton Transactions
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pyramidal with Cl(1A) in the apical position (the four atoms of
the basal plane are coplanar to ca. 0.23 Å with the metal lying
ca. 0.63 Å out of this plane). By contrast the coordination geo-
metries at the Zn(2) centres are very similar in both indepen-
dent cations, each having a square-based pyramidal geometry
with Cl(3) in the apical site; the four coordinated nitrogen
centres are coplanar to within ca. 0.03 and 0.02 Å in 8-A and 8-
B respectively, with Zn(2) lying ca. 0.83 Å (8-A) and 0.80 Å (8-B)
out of this plane.
The two independent cations are both arranged in π–π
linked dimer pairs across a centre of symmetry, with in each
case the N(1)-based pyridyl ring in one cation overlaying the
N(14)-based ring in the Ci-related counterpart, and vice versa
(for cation 8-A: centroid⋯centroid and mean interplanar sep-
arations of ca. 3.72 and 3.33 Å, rings inclined by ca. 3°, inter-
action a in Fig. 9, and for cation 8-B: centroid⋯centroid and
mean interplanar separations of ca. 3.56 and 3.42 Å, rings
inclined by less than 1°, interaction b in Fig. 9). These dimer
pairs are then joined by a further π–π interaction across an
independent centre of symmetry between the “unused” pyridyl
rings based on N(8) (centroid⋯centroid and mean interplanar
separations of ca. 3.65 and 3.39 Å, rings inclined by ca. 13°,
interaction c in Fig. 9) forming the extended ⋯AA⋯B-
B⋯AA⋯BB⋯ chain shown in Fig. 9.
Crystals of the di-copper complex 9 were obtained from
slow diﬀusion of acetone into concentrated aqueous solution
of the complex. The cation in the structure of this di-nuclear
complex (Fig. 10, Table 1) has an approximately planar ter-
pyridine unit with the Cu(1) centre lying ca. 0.13 Å out of the
N3 plane (the torsion angles between the N(1)- and N(8)-based
rings, and between the N(1)- and N(14)-based rings being less
than 1° and ca. 3° respectively). The coordination geometry at
the Cu(1) atom is distorted square based pyramidal with Cl(1)
in the apical position. (The four atoms of the basal plane are
coplanar to ca. 0.15 Å with the metal lying ca. 0.31 Å out of
this plane.) The coordination geometry at Cu(2) is a much less
distorted square-based pyramid with Cl(3) in the apical site;
the four coordinated nitrogen centres are coplanar to within
ca. 0.01 Å, with Cu(2) lying ca. 0.51 out of this plane.35
The cations are arranged in π–π linked dimer pairs across a
centre of symmetry, with the N(1)-based pyridyl ring in one
cation overlaying the N(8)-based ring in the Ci-related counter-
part, and vice versa (centroid⋯centroid and mean interplanar
separations of ca. 3.67 and 3.36 Å, rings inclined by less than
1°, interaction a in Fig. 11). These dimer pairs are then joined
across a C2-axis by a further π–π interaction between the
“unused” pyridyl rings based on N(14) (centroid⋯centroid and
mean interplanar separations of ca. 3.81 and 3.62 Å, rings
inclined by less than 1°, interaction b in Fig. 11) forming an
Table 1 Selected bond lengths (Å) and angles (°) for 8-A, 8-B and 9
8-A [M = Zn] 8-B [M = Zn] 9 [M = Cu]
M(1)–Cl(1) 2.2614(8) 2.2678(8) 2.5361(17)
M(1)–Cl(2) 2.2903(7) 2.2680(7) 2.2341(18)
M(1)–N(1) 2.094(2) 2.077(2) 1.944(5)
M(1)–N(8) 2.183(2) 2.175(3) 2.051(4)
M(1)–N(14) 2.193(2) 2.205(2) 2.030(6)
Cl(1)–M(1)–Cl(2) 109.38(3) 113.46(3) 101.61(7)
Cl(1)–M(1)–N(1) 114.19(6) 116.47(7) 102.66(12)
Cl(1)–M(1)–N(8) 106.41(7) 96.22(7) 94.06(12)
Cl(1)–M(1)–N(14) 97.47(6) 97.65(6) 96.10(15)
Cl(2)–M(1)–N(1) 136.40(6) 130.07(7) 155.73(13)
Cl(2)–M(1)–N(8) 94.80(6) 99.28(7) 98.34(14)
Cl(2)–M(1)–N(14) 98.85(6) 99.02(6) 98.4(2)
N(1)–M(1)–N(8) 74.91(8) 75.24(9) 79.71(17)
N(1)–M(1)–N(14) 74.25(8) 75.10(8) 79.3(2)
N(8)–M(1)–N(14) 146.69(9) 150.33(9) 158.3(2)
Fig. 9 Part of one of the π–π linked chains of cations present in the crystal of 8. The π–π stacking interactions have centroid⋯centroid and mean
interplanar separations (Å) of (a) 3.72, 3.33, (b) 3.56, 3.42 and (c) 3.65, 3.39 respectively.
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extended chain along the crystallographic c-axis direction
(Fig. 11).
Biophysical studies to determine the interactions between
metal complexes and DNA
We first investigated the aﬃnity of the complexes towards two
quadruplexes (human telomeric, Htelo, and c-Myc DNA) and
duplex ds26 DNA by fluorescent intercalator displacement
(FID) assays.31,36 The results presented as DC50 values in
Table 2 (i.e. the concentration at which 50% of thiazole orange
(TO) had been displaced) indicates that several of the com-
plexes are excellent quadruplex binders (with DC50 < 0.4 µM)
and in some cases considerably selective over duplex ds26
DNA. It can also be observed that most of the complexes
display lower DC50 values (i.e. higher aﬃnity) for c-Myc than
Htelo DNA.
Since FID assays are semiquantitative and therefore provide
only an overview of the binding aﬃnities between small mole-
cules and DNA, a second technique to assess the binding was
employed. Thus, UV-Vis spectroscopic studies were carried out
with the corresponding complexes and DNA (Htelo, c-Myc and
ct-DNA – the latter as an example of duplex DNA), using a pre-
viously established protocol.37 In order to perform these
studies the test compounds were required to have an absorp-
tion maximum above 300 nm (higher than the λmax of DNA,
260 nm) and show optical changes when interacting with
DNA. As the free ligands did not have absorption bands above
300 nm, only the metal complexes were tested. Due to the poor
binding aﬃnity of 1 and 2 to quadruplex DNA (as determined
from the FID assay), these complexes were omitted from the
UV-vis titration studies. Upon addition of aliquots of DNA (in
the mM range) to solutions of the corresponding metal com-
plexes, the absorption maximum was seen to decrease. From
the absorption values, the concentrations of bound and
unbound metal complex were calculated and extrapolated to
determine the binding constants. This was done by fitting the
data to a reciprocal plot of D/Δεap versus D using the following
equation: D/Δεap = D/Δε + 1/(Δε × K) where the concentration
of DNA (D) is expressed in terms of base pairs (determined by
measuring the absorption at 260 nm and the appropriate
extinction coeﬃcients), the apparent molar extinction coeﬃ-
cient εa = Aobserved/[Complex], Δεap = [εa − εf ] and Δε = [εb − εf ].
εb is the extinction coeﬃcient of the DNA bound complex, and
εf is the extinction coeﬃcient of the free complex.
38 The intrin-
sic binding aﬃnities toward the diﬀerent DNA sequences were
determined and are summarised in Table 3. These studies
showed that most of the complexes have good aﬃnity towards
quadruplex DNA and they have generally higher aﬃnity for
c-Myc DNA over Htelo DNA and quadruplex DNA over ct-DNA.
In particular, complexes 9–12 (with the pyridine-cyclen ligand
L4) showed to have very high aﬃnity towards G-quadruplexes –
particularly c-Myc – and, up to 1000-fold selectivity over
ct-DNA. The rationale for developing these complexes in the
first place, was to test whether the addition of a second metal
complex to the square planar platinum(II)-terpyridine or the
square-based pyramidal copper(II)-terpyridine complexes
would yield better quadruplex DNA binders. In particular, we
chose the cyclen unit as a second coordinating ligand because:
(a) cyclen does not coordinate with high aﬃnity to platinum(II)
and therefore it was possible to prepare mixed-metal com-
plexes (11 and 12); (b) zinc(II)-cyclen complexes have been pre-
viously reported to have good aﬃnity for phosphates39–42 and
hence we rationalised that this type of moiety would be able to
Fig. 10 The structure of the cationic complex present in the crystal
of 9.
Fig. 11 Part of one of the π–π linked stacks of cations along the c-axis
direction present in the crystal of 9. The π–π stacking interactions have
centroid⋯centroid and mean interplanar separations (Å) of (a) 3.67, 3.36
and (b) 3.81, 3.62 respectively.
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interact with the phosphate backbone of DNA; furthermore, it
is well established that zinc(II)-cyclen complexes have high
aﬃnity for thymine and therefore one could expect strong
interactions with bases in the loops of DNA.43–47 Indeed, the
results obtained indicate that these bi-metallic complexes are
excellent quadruplex DNA binders and the cyclen unit seems
to provide them with high aﬃnity over duplex DNA (even for
complex 10 where the cyclen is metal-free).
UV-Vis spectroscopic titrations were also used to probe the
binding mode between the complexes and the diﬀerent DNA
structures. Red shifts in absorption bands above 300 nm
(those corresponding to MLCT or intraligand π–π* transitions)
are characteristic of π–π42 interaction with DNA bases.48–50
This is generally suggestive of intercalative (for duplex DNA) or
end-stacking (for quadruplex DNA) binding modes. The
addition of Htelo DNA to the mono-platinum(II) terpyridine
complexes 3–7, resulted in considerable hypochromicity of the
metal perturbed intraligand π–π* band (ranging from
22–33%). A noticeable red shift (4–6 nm) was also observed for
the complexes. These spectral features are suggestive of an
end-stacking binding mode. Interestingly upon addition of
c-Myc DNA, reduced hypochromicity (9–15%) and very small
red shifts (1–2 nm) were observed. The latter suggests binding
to c-Myc DNA may not necessarily be restricted to end-stacking
but could also involve supplementary interactions with the
DNA’s loops and phosphate backbone. On the other hand, for
the mono-platinum(II) phenanthroline-based complexes
(13–15), addition of DNA (quadruplex and duplex) resulted in
large hypochromicity (ranging from 18–38%) but no red shift.
This suggests that for these complexes binding may not exclu-
sively result from π–π stacking interactions. For complexes
9–12, significant hypochromicity was seen upon addition of
Htelo, c-Myc and ct-DNA (9–25%) but no significant batho-
chromicity (red shift) was observed. This again suggests that
the binding mode of these complexes to DNA is not exclusively
a result of π–π stacking interactions but rather a combination
of this binding mode and an electrostatic and covalent inter-
action. Indication of more than one binding mode can be
rationalised by the dual targeting nature if the complexes: via
π–π stacking interactions atop quadruplex DNA (with the
metal-terpyridine core) as well as through electrostatic or
covalent interactions (via the metal cyclen) to bases/phosphate
backbone in the loops. Further structural studies are underway
to establish the exact binding mode of these complexes with
G-quadruplex DNA.
Cytotoxicity of metal complexes
Having established the high aﬃnity of most of the complexes
under investigation towards quadruplex DNA, we were inter-
ested in assessing their cytotoxicity. Thus MTS assays were
carried out (using the CellTiter 96® AQueous Assay from
Promega) on the complexes with two cell lines: human osteo-
sarcoma (U2OS) and normal fibroblast (GM05757). U2OS cells
expresses high levels of c-Myc protein making it a useful cell
line for testing the anti-cancer properties of the synthesised
quadruplex binders. GM05757 is a normal human fibroblast
cell line which was used as a control.
Table 2 DC50 values obtained for the metal(II) complexes. The values are an average of three independent measurements (errors were within 5%).
The DC50 values for 1–4 have been previously reported.
16,17
Compound
TO displacement Selectivity
HteloDC50 (μM) cmycDC50 (μM) ds26DC50 (μM) ds26DC50/HteloDC50 ds26DC50/cmycDC50
1 >10 >10 >10 — —
2 1.32 2.45 2.16 1.6 —
3 1.25 0.26 2.44 2.0 9.4
4 2.24 1.01 >2.50 1.1 2.5
5 0.46 0.30 0.68 1.5 2.3
6 0.33 0.49 1.17 3.5 2.4
7 0.48 0.30 1.18 2.5 3.9
8 2.75 0.86 3.34 1.2 3.9
9 0.21 0.09 0.60 2.9 6.7
10 0.28 0.16 0.70 2.5 4.4
11 0.35 0.08 1.50 4.3 18.8
12 0.18 0.17 0.77 4.3 4.5
13 0.66 0.27 1.18 1.8 4.4
14 0.40 0.13 0.71 1.8 5.5
15 1.01 0.25 1.77 1.8 7.1
Table 3 DNA aﬃnity constants from UV/Vis spectroscopic titrations.
Values are an average of 3 independent measurements. The previously
reported K values for 3 are included for comparison17
Compound c-MycK (M−1) HteloK (M−1) ct-DNAK (M−1)
3 6.33 ± 0.32 × 106 1.83 ± 0.57 × 106 9.24 ± 0.72 × 104
4 1.64 ± 0.32 × 107 1.75 ± 0.53 × 106 2.18 ± 0.23 × 105
5 4.87 ± 0.44 × 107 1.95 ± 0.29 × 106 1.10 ± 0.23 × 106
6 1.32 ± 0.42 × 107 1.06 ± 0.11 × 107 1.95 ± 0.52 × 105
7 6.85 ± 0.24 × 107 1.60 ± 0.72 × 107 5.46 ± 1.10 × 105
8 7.45 ± 1.05 × 106 1.12 ± 0.45 × 106 2.40 ± 1.56 × 105
9 5.57 ± 3.58 × 108 1.46 ± 0.19 × 107 2.80 ± 0.41 × 105
10 1.12 ± 0.55 × 108 1.47 ± 0.93 × 107 1.92 ± 1.39 × 105
11 2.81 ± 0.31 × 108 1.90 ± 1.27 × 107 4.00 ± 2.06 × 105
12 1.41 ± 0.94 × 108 2.35 ± 0.35 × 107 9.43 ± 1.11 × 105
13 1.42 ± 0.10 × 107 6.21 ± 1.56 × 106 5.20 ± 1.32 × 105
14 1.14 ± 0.22 × 107 1.46 ± 0.15 × 106 1.07 ± 0.21 × 106
15 5.52 ± 0.42 × 106 8.00 ± 1.23 × 105 4.35 ± 1.19 × 104
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The IC50 values were determined for all the compounds
under study with cisplatin employed as metal-containing
control compound (Table 4). In general, the compounds had
slightly higher toxicity towards the U2OS cells compared to
GM05757 cell line. Under the conditions used, mono-platinum(II)
complexes with chloride in the fourth coordination site (3, 4,
10, 13 and 15) gave EC50 values ranging between 57 and 95 μM
for the U2OS cell line, which are comparable to cisplatin
under the same conditions (EC50 = 48 μM). Similarly, the di-
metallic complexes 11 and 12 which contain a [Pt(trpy)Cl]+
unit, displayed high cytotoxicity against U2OS (EC50 = 64 and
49 μM respectively) while the di-zinc and di-copper complexes
were less potent (EC50 = 463 and 290 μM respectively). On the
other hand, platinum(II) complexes with thiolate in the fourth
coordination position (5–7 and 14) were found to be non-toxic
(up to a concentration of 500 μM) for the two cell lines. It is
well established that platinum(II) complexes containing Pt–Cl
bonds (and more specifically [Pt(trpy)Cl]+ complexes), over
time can hydrolyse to yield aquated complexes which even-
tually can coordinate to DNA. Therefore we propose that the
high toxicity found for complexes 3, 4, 10, 13 and 15 may
result from their ability to platinate DNA or perhaps some
other biomolecules over time. Platinum(II)-thiol complexes, on
the other hand, are relatively resistant to aquation because of
their strong Pt–S bond and therefore do not platinate DNA
sequences readily (see previous reports by Lippard et al. on the
use of (trpy)Pt-thiolate complexes as metallo-intercaltors51–53).
This probably explains their lack of toxicity against the cell
lines tested over a 24 h period. The di-copper complex 9, on
the other hand, displayed higher cytotoxicity against GM05757
cell line (155 ± 7 µM) than against U2OS (290 ± 64 µM) –
although it should be noted that this is not particularly high
for either of the two cell lines. The presence of copper(II)
centres in this complex is likely to induce oxidative damage to
DNA and hence the observed cytotoxicity might be due to this
process rather than by targeting quadruplexes (for which 9 has
a high aﬃnity – see Table 2).
Cellular uptake
Cellular uptake studies were carried out to determine the cell
permeability and localisation of a selection of the complexes.
In particular, we were interested to establish whether the low
cytotoxicity of compounds 7 and 14 (as representatives of the
thiolated complexes) was due to their inability to aquate due
to the thiolate being in the fourth coordination position rather
than their inability to enter the cell. Thus, U2OS cells were
incubated for 24 h at 37 °C with sub-lethal concentrations
(10 μM) of two platinum-terpyridine complexes, 3 and 7 (with
Cl and thiolate respectively in the fourth coordination posi-
tion), and two platinum-phenanthroline complexes, 14 and 15
(with Cl and thiolate respectively in the fourth coordination
position). The platinum content of the treated cells was deter-
mined for whole cell, nucleus and cytoplasm using inductively
coupled plasma mass spectrometry (ICP-MS). Cellular plati-
num levels are expressed as ng of Pt/mg of protein and the
results reported are a mean of seven determinations for each
data point (see Fig. 12).
The platinum(II)-terpyridine complexes (3 and 7) were
found to be taken up by U2OS cells (between 5 and 15% of the
administered complexes at 10 μM). More importantly the com-
plexes were also found to enter the nucleus (>0.5 ng of Pt/mg
of protein corresponding to 2–8% of the added complexes, was
found in the nuclear fractions). The cellular uptake values are
comparable to those obtained for other platinum(II) ter-
pyridine-like complexes previously reported.54,55 Yet, for
complex 7, cytotoxicity is low implying the thiolate eﬀectively
prevents non-specific coordination to proteins and/or DNA.
The platinum(II) pyridyl-phenanthroline complex 15 was also
taken up by the cells (4% of the administered amount).
However, in contrast, the thiol functionalised platinum(II)
pyridyl-phenanthroline complex 14 was not taken up by cells,
consistent with its low cytotoxicity.
Fig. 12 Cellular uptake data for a selection of the complexes under
study. The amount of platinum or copper (ng) per protein (mg) is
expressed for the whole cell, cytoplasm and nucleus.
Table 4 EC50 values obtained for the metal(II) complexes against U2OS
and GM07575 cell lines. The values are an average of three independent
measurements
Compound U2OS EC50 (µM) GM07575 EC50 (µM)
3 61 ± 7 130 ± 12
4 95 ± 11 225 ± 26
5 >500 >500
6 >500 >500
7 >500 >500
8 463 ± 9 339 ± 81
9 290 ± 64 155 ± 7
10 57 ± 12 121 ± 5
11 64 ± 11 132 ± 8
12 49 ± 8 95 ± 1
13 74 ± 12 180 ± 15
14 >500 >500
15 79 ± 15 98 ± 5
Cisplatin 48 ± 6 74 ± 6
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Conclusions
Two new ligands and ten new metal complexes have been
successfully prepared and their ability to bind to quadruplex
DNA structures (c-Myc and HTelo) demonstrated. In general,
most of the complexes were shown to bind c-Myc quadruplex
DNA more strongly than ct-DNA and also bind to c-Myc quad-
ruplex better than to Htelo quadruplex DNA. The complexes
that display the highest aﬃnity and selectivity for quadruplex
DNA are those with the new terpyridine-cyclen ligand L4. In
particular, the bimetallic complexes containing a square
planar PtII-terpy unit plus a copper(II) or zinc(II)-cyclen moiety,
display very high aﬃnities for c-Myc quadruplex DNA (ca.
108 M−1) and up to 1000-fold selectivity over ct-DNA. This is
likely to be due to a dual type of interaction where the plati-
num-terpy complex binds via end stacking with the G-tetrad
(at least initially) and the metal-cyclen unit interacts with the
loops of the quadruplex. Interestingly, even complex 10, which
contains a platinum-terpyridine moiety and a metal-free
cyclen, displays very high aﬃnities. It is possible that in this
case the cyclen is highly protonated and therefore is able to
display strong electrostatic interactions with the negatively-
charged phosphate backbone of DNA.
For the platinum(II) complexes, we have shown that the
nature of the ligand in the fourth coordination position plays
an important role in their cytotoxicity. Complexes with chlor-
ide in the fourth coordination position have higher cytotoxicity
than their thiolated counterparts. This is consistent with pre-
vious observations showing that [Pt(trpy)Cl]+ complexes, once
inside the cell, can be readily aquated and therefore platinate
(by direct coordination) DNA.
Cellular uptake studies showed that complexes 3, 7 and 15
are taken up by U2OS cells and localise in the nucleus whereas
phenanthroline-platinum complex 14 is not cell permeable.
Therefore, these results indicate that the low cytotoxicity of 14
is associated with poor uptake. Conversely, the low cytotoxicity
of 7 is not due to cell permeability issues. Hence it is proposed
that the coordinated thiolate prevents it from platinating DNA.
Further studies are underway to determine in more detail the
quadruplex DNA binding mode of these complexes.
Experimental section
General procedures
1H NMR, 13C NMR and 31P NMR spectra were recorded on a
BrukerAvance 400 MHz Ultrashield NMR spectrometer. Elec-
tron spray ionisation mass spectra were recorded on a Bruker-
Daltronics Esquire 3000 spectrometer. Elemental analysis of
the compounds prepared was performed by Mr Alan Dickerson
(University of Cambridge). Cyc-Tri-BOC,32 L1–L3 and 1–416,17
were prepared as previously reported. L1 was purchased from
Sigma Aldrich and its purity was checked by 1H NMR spectro-
scopy prior to use. [PtCl(L1)]Cl, 13, L5 and L6 were prepared by
small modifications of reported procedures33,34,56 and their
successful syntheses confirmed by comparing the spectro-
scopic data with that reported in the literature. All oligonucleo-
tides used were purchased from Eurogentec SA.
Synthesis
Synthesis of L4-BOC. A solution of Cyc-Tri-BOC32 (0.086 g,
0.145 mmol) in acetone (10 mL) was added dropwise to a
stirred refluxing mixture of 2,6-bis(2-pyridyl) 4(1H) pyridone
(0.037 g, 0.149 mmol) and potassium carbonate (0.082 g,
0.596 mmol) in acetone (15 mL). The stirred mixture was
heated under reflux for 48 h. After this time, the mixture was
filtered to remove inorganic salts, water was added to the fil-
trate and the product was extracted into diethyl ether (20 mL ×
2). The combined organic extracts were washed with water,
5% sodium hydroxide and water then dried with Na2SO4. The
solvent was removed under reduced pressure to yield an
oﬀ-white solid (81 mg, 74%); 1H NMR (400 MHz, CDCl3):
δH 8.71 (d, 2H,
3JHH = 8.0, tpy 2-H), 8.64 (d, 2H,
3JHH = 8.0, tpy
5-H), 8.03 (s, 2H, tpy′ 3-H and 5-H), 7.88 (dd, 2H, 3JHH = 8.0,
8.0, tpy 4-H), 7.37 (dd, 2H, 3JHH = 8.0, 8.0, tpy 3-H), 4.28 (t, 2H,
3JHH = 6.0, propyl 3-H), 3.60–2.60 (br m, 16H, cyclen), 2.83 (t,
2H, 3JHH = 8.0, propyl 1-H), 2.06 (m, 2H, propyl 2-H), 1.48 (s,
27H, Boc-CH3);
13C NMR (400 MHz, CDCl3): δC 179.0, 166.9,
157.3, 156.1, 149.1, 136.6, 123.9, 121.3, 107.3, 79.5, 79.1, 66.6,
54.6, 54.3, 50.1, 49.1, 29.3, 23.9; ESI-MS Calcd for C41H59N7O7
[M]+: 762 a.m.u. Found [M + H]+: 763 a.m.u.
Synthesis of L4. L4-BOC (0.045 g, 0.057 mmol) was dissolved
in a solution of dichloromethane–TFA (1 : 1) (5 mL) and stirred
at room temperature for 24 h. The solvents were then removed
under reduced pressure and the resulting solid dried. This
solid was then dissolved in water and NaOH 2 M (aq) was
added dropwise until the solution became alkaline (pH 12).
The product was then extracted into dichloromethane. The
solvent was removed under reduced pressure to yield a pale
yellow sticky solid (0.016 g, 67%); 1H NMR (400 MHz, DMSO-
d6): δH 8.74 (d, 2H,
3JHH = 8.0, tpy 2-H), 8.66 (d, 2H,
3JHH = 8.0,
tpy 5-H), 8.06 (dd, 2H, 3JHH = 8.0, 8.0, tpy 4-H), 8.02 (s, 2H, tpy′
3-H and 5-H), 7.55 (dd, 2H, 3JHH = 8.0, 8.0, tpy 3-H), 4.32 (t,
2H, 3JHH = 4.0, propyl 3-H), 3.12–2.82 (br m, 16H, cyclen), 2.92
(t, 2H, 3JHH = 4.0, propyl 1-H), 2.01 (m, 2H, propyl 2-H); (for
COSY 1H–1H NMR see Fig. S1 in ESI†); 13C NMR (400 MHz,
DMSO-d6): δC 166.6, 156.3, 154.6, 148.9, 137.0, 124.2, 120.8,
106.4, 65.7, 51.4, 50.5, 47.3, 46.0, 44.9, 26.0; 19F NMR
(400 MHz, DMSO-d6): absence of peak at δF −77.8 indicates no
triflate left; IR (cm−1): 1672, 1585, 1565, 1464, 1444, 1420,
1393, 1198, 1127, 1008, 871, 828, 794, 744, 719; ESI-MS Calcd
for C26H35N7O [M]
+: 461 a.m.u. Found [M + H]+: 462 a.m.u.
Synthesis of L7. 5-Chloro-1,10-phenanthroline (200 mg,
0.94 mmol) and 1-(2-hydroxyethyl)piperidine (146 mg,
0.94 mmol) were slowly added to a stirred suspension of
powered KOH (264 mg, 5.0 mmol) in DMSO (5 ml). The solu-
tion was stirred under nitrogen at 60 °C for 4 h. The reaction
mixture was extracted with CH2Cl2 (50 ml × 3), washed
thoroughly with water (30 ml × 3) and dried over sodium sul-
phate. The solvent was removed under reduced pressure to
yield the product as a brown solid (212 mg, 73%); 1H NMR
(400 MHz, CDCl3): δH 9.23 (dd, 1H,
3JHH = 6.0, 2.0, phen 2-H),
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9.05 (dd, 1H, 3JHH = 6.0, 2.0, phen′ 2-H), 8.71 (dd, 1H,
3JHH =
8.0, 2.0, phen 4-H), 8.14 (dd, 1H, 3JHH = 8.0, 2.0, phen′ 4-H),
7.68 (dd, 1H, 3JHH = 8.0, 4.0, phen 3-H), 7.59 (dd, 1H,
3JHH =
8.0, 4.0, phen′ 3-H), 7.00 (s, 1H, phen 5-H), 4.44 (t, 2H, 3JHH =
6.0, ethyl 1-H), 3.03 (t, 2H,3JHH = 6.0, ethyl 2-H), 2.65 (m, 4H,
pip 1-H), 1.67 (m, 4H, pip 2-H), 1.51 (m, 2H, pip 3-H); 13C
NMR (400 MHz, DMSO-d6): δC 152.1, 150.6, 147.9, 134.6, 130.9,
129.2, 123.7, 123.2, 122.6, 101.7, 66.9, 57.8, 55.2, 26.0, 24.1;
ESI-MS Calcd for C19H21N3O [M]
+: 307.2 a.m.u. Found [M +
H]+: 308.0 a.m.u.; Anal. Calcd for C19H21N3O·1.45H2O: C 68.42,
H 7.22, N 12.60; Found: C 68.86, H 6.76, N 12.58.
Synthesis of L8. nButyl-lithium (2 M solution in cyclohexane,
0.81 ml, 1.63 mmol) was added dropwise to a solution of
2-bromopyridine (0.16 ml, 1.63 mmol) in dry THF (7 ml)
under nitrogen at −78 °C. The resultant deep red solution was
stirred for 15 min. A solution of L7 (100 mg, 0.33 mmol) in dry
THF (5 ml) was then added via a cannula to the lithiated reac-
tion mixture. The reaction was allowed to proceed for 2.5 h.
After this period, water (30 ml) was added to quench the reac-
tion and the organic material was extracted with DCM (50 ml ×
3). The reaction products were re-oxidised by incubating the
DCM solution with MnO4 (3 g) for 2 h. MnO4 was filtered and
then dried using NaSO4. The solvent was then removed under
reduced pressure to give the crude product as a brown oil. The
crude product was purified by alumina column chromato-
graphy using a THF–hexane–Et3N (5 : 1 : 0.02) solvent system to
give L8 as an oﬀ-white oily-solid (0.21 g, 21%); 1H NMR
(400 MHz, CDCl3): δH 9.09 (dd, 1H,
3JHH = 4.0, 2.0, phen 2-H),
9.02 (dd, 1H, 3JHH = 8.0, pyridyl 2-H), 8.83 (s, 1H, phen 7-H),
8.82 (d, 1H, 3JHH = 4.0, phen 9-H), 8.78 (dd, 1H,
3JHH = 4.0, 2.0,
phen 4-H), 8.15 (dd, 1H, 3JHH = 4.0, 2.0, phen 10-H), 7.94 (td,
1H, 3JHH = 4.0, 2.0, pyridyl 4-H), 7.60 (dd, 1H,
3JHH = 4.0,2.0,
pyridyl 3-H), 7.40 (dd, 1H, 3JHH = 4.0, 2.0, phen 3-H), 7.28 (m,
1H, pyridyl 5-H), 4.46 (t, 2H, 3JHH = 6.0, ethyl 1-H), 3.06 (t, 2H,
3JHH = 6.0, ethyl 2-H), 2.66 (m, 4H, pip 1-H), 1.68 (m, 4H, pip
2-H), 1.51 (m, 2H, pip 3-H); ESI-MS Calcd for C24H24N4O [M]
+:
384.2 a.m.u. Found [M + Na]+: 407.0 a.m.u.
Synthesis of 5. [PtCl(L1)]Cl (100 mg, 0.19 mmol) and L5
(108 mg, 0.76 mmol) were stirred in water (10 ml) at room
temperature for 48 h to aﬀord a deep purple solution. After
removing excess thiol by extraction with diethyl ether (10 ml × 3)
the aqueous layer was removed under reduced pressure. The
resultant solid was washed thoroughly with diethyl ether
(20 ml). The desired complex was isolated as dark red crystals
(80 mg, 71%); 1H NMR (400 MHz, D2O): δH 8.93 (d, 2H,
3JHH =
6.0, tpy 2-H), 8.29 (t, 1H, 3JHH = 8.0, tpy′ 4-H), 8.24 (t, 2H,
3JHH
= 8.0, 4.0, tpy 4-H), 8.11 (d, 2H, 3JHH = 8.0, tpy 5-H), 8.07 (d,
2H, 3JHH = 8.0, tpy′ 3-H and 5-H), 7.68 (t, 2H,
3JHH = 6.0, 4.0,
tpy 3-H), 3.18 (m, 3H, ethyl 1-H and pip N+–H), 2.99 (br s, 4H,
pip 1-H), 2.63 (t, 2H, 3JHH = 8.0, ethyl 2-H), 1.62 (br s, 4H, pip
2-H), 1.45 (br s, 2H, pip 3-H); 13C NMR (400 MHz, D2O):
δC 158.78, 153.40, 152.19, 142.70, 129.53, 129.12, 126.02,
124.45, 59.59, 52.52, 23.68, 22.86, 21.43; ESI-MS Calcd for
C22H26Cl2N4PtS [M]
+: 643.2 a.m.u. Found [M − 2Cl]+: 572.0
a.m.u.; Anal. Calcd for C22H26Cl2N4PtS·3H2O: C 37.83, H 4.62,
N 8.02; Found: C 37.83, H 4.22, N 7.82.
Synthesis of 6. Complex 3 (100 mg, 0.16 mmol) and L5
(139 mg, 0.96 mmol) were stirred in water (15 ml) at 40 °C for
48 h to aﬀord an orange solution. After removing excess thiol
by extraction with diethyl ether (20 ml × 3) the aqueous layer
was removed under reduced pressure. The resultant solid was
purified by alumina column chromatography using 100%
DCM to give the product as a chloride salt. In order to form
the PF6 salt the solid was dissolved in the minimum amount
of DMSO, to which excess NaPF6 (as an aqueous solution) was
added dropwise. This yielded a red precipitate which was iso-
lated by filtration and washed repeatedly diethyl ether. The di-
arm complex was isolated as an orange powder (15 mg, 13%);
1H NMR (400 MHz, DMSO-d6): δH 9.40 (d, 2H,
3JHH = 4.0, tpy
2-H), 8.73 (d, 2H, 3JHH = 6.0, tpy 5-H), 8.59 (t, 2H,
3JHH = 6.0,
tpy 4-H), 8.42 (s, 2H, tpy′ 3-H and 5′-H), 8.03 (t, 2H, 3JHH = 6.0,
tpy 3-H), 4.77 (t, 2H, 3JHH = 4.0, O-ethyl 1-H), 3.70 (t, 2H,
3JHH =
4.0, O-ethyl 2-H), 3.60 (br s, 4H, O-pip 1-H), 3.12 (m, 2H,
S-ethyl 1-H), 2.82 (m, 2H, S-ethyl 2-H), 1.90 (m, 4H, S-pip 1-H),
1.74 (m, 10H, S-pip 2-H, O-pip 2-H and pip N+–H), 1.55 (m,
4H, S-pip 3-H, O-pip 3-H); 31P NMR (400 MHz, DMSO-d6):
δP −144.19 (sept, 3P, 1JPF = 1760, PF6); ESI-MS Calcd for
C29H40F18N5OP3PtS [M]
+: 1135.2 a.m.u. Found [M − PF6]+:
991.0 a.m.u., [M − 2PF6]+: 846.0 a.m.u., [M − 3PF6]+: 699.2
a.m.u.; Anal. Calcd for C29H40F18N5OP3PtS·H2O: C 30.16,
H 3.67, N 6.07; Found: C 29.71, H 3.63, N 5.71.
Synthesis of 7. Complex 4 (100 mg, 0.16 mmol) and L5
(139 mg, 0.96 mmol) were stirred in water (15 ml) at 40 °C for
48 h to aﬀord an orange solution. After removing excess thiol
by extraction with diethyl ether (20 ml × 3) the aqueous layer
was removed under reduced pressure. The resultant solid was
dissolved in the minimum amount of DMSO, to which excess
NaPF6 (as an aqueous solution) was added dropwise. This
yielded a red precipitate which was isolated by filtration and
washed repeatedly diethyl ether. The di-arm complex was iso-
lated as an orange powder (23 mg, 21%); 1H NMR (400 MHz,
DMSO-d6): δH 9.39 (d, 2H,
3JHH = 4.0, tpy 2-H), 8.70 (d, 2H,
3JHH = 6.0, tpy 5-H), 8.57 (t, 2H,
3JHH = 6.0, tpy 4-H), 8.41 (s,
2H, tpy′ 3-H and 5-H), 8.01 (t, 2H, 3JHH = 6.0, tpy 3-H), 4.70 (br
s, 2H, O-ethyl 1-H), 4.07 (br s, 2H, O-ethyl 2-H), 3.76 (br s, 4H,
O-mor, 1-H), 3.60 (br s, 4H, O-mor, 2-H), 3.09 (t, 2H, 3JHH = 8.0,
S-ethyl 1-H), 2.95 (t, 2H, 3JHH = 8.0, Sethyl 2-H), 2.82 (m, 4H,
S-pip, 1-H), 1.78 (m, 4H, S-pip, 2-H), 1.61 (m, 2H, pip N+–H
and mor N+–H), 1.33 (m, 2H, S-pip 3-H); 31P NMR (400 MHz,
DMSO-d6): δP −144.20 (sept, 3P, 1JPF = 1752, PF6); ESI-MS Calcd
C28H38F18N5O2P3PtS [M]
+: 1136.1 a.m.u. Found [M − PF6]+:
993.2 a.m.u., [M − 2PF6]+: 847.2 a.m.u., [M − 3PF6]+: 701.2
a.m.u.; Anal. Calcd for C28H38F18N5O2P3PtS·3H2O: C 28.20, H
3.72, N 5.87; Found: C 28.02, H 3.44, N 5.50.
Synthesis of 8. L4 (0.020 g, 0.043 mmol) was dissolved in
methanol (3 ml) and added to a solution of ZnCl2 (0.012 g,
0.086 mmol) in methanol (2 mL). A white precipitate was seen
to form immediately. The solution was heated to 40 °C and set
to stir for 48 h. The solution was then allowed to cool and the
oﬀ-white solid was filtered and washed with methanol and
diethyl ether and dried under vacuo (0.022 g, 71%); 1H NMR
(400 MHz, DMSO-d6): δH 8.81 (d, 2H,
3JHH = 8.0, tpy 2-H), 8.79
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(d, 2H, 3JHH = 8.0, tpy 5-H), 8.37 (s, 2H, tpy′ 3-H and 5-H), 8.33
(dd, 2H, 3JHH = 8.0, 8.0, tpy 4-H), 7.88 (dd, 2H,
3JHH = 8.0, 8.0,
tpy 3-H), 4.50 (br, 2H, propyl 3-H), 3.00–2.60 (br m, 18H,
cyclen and propyl 1-H), 2.21 (m, 2H, propyl 2-H); (for COSY
1H–1H NMR see Fig. S1 in ESI†); 13C NMR (400 MHz, DMSO-
d6): δC 170.0, 150.3, 148.8, 147.0, 140.5, 127.0, 122.0, 109.2,
68.4, 49.4, 49.1, 44.2, 43.2, 42.0, 21.7; ESI-MS Calcd for
C26H35Cl5Zn2.5N7O [M]
+: 797 a.m.u. Found [M − 0.5ZnCl4]+:
698 a.m.u.; Anal. Calcd for C26H35Cl5N7OZn2.5·2H2O: C, 37.25;
H, 4.69; N, 11.69; Found: C 36.92, H 4.27, N 11.19.
Synthesis of 9. L4 (0.020 g, 0.043 mmol) was dissolved in
methanol (3 ml) and added to a solution of CuCl2·2H2O
(0.015 g, 0.086 mmol) in methanol (2 mL). A blue precipitate
was seen to form immediately. The solution was heated to
40 °C and set to stir for 48 h. The solution was then allowed to
cool and the blue solid was filtered and washed with diethyl
ether and dried under vacuo (0.021 g, 68%); IR (cm−1): 1613,
1563, 1475, 1441, 1366, 1225, 1081, 1058, 1040, 1022, 991, 858,
803, 726, 700; UV/Vis (DMSO) λmax/nm (ε/cm
−1 M−1): 317
(11 080), 331 (8940); ESI-MS Calcd for C26H35Cl4Cu2N7O [M]
+:
729 a.m.u. Found [M − Cl]+: 694 a.m.u.; Anal. Calcd for
C26H35Cl4Cu2N7O·3H2O: C, 39.80; H, 5.27; N, 12.50; Found: C
39.44, H 4.96, N 12.24.
Synthesis of 10. L4 (0.020 g, 0.043 mmol) was dissolved in
DMSO (2 mL) and added to a solution of K2PtCl4 (0.020 mg,
0.047 mmol) in DMSO (2 mL). The solution was heated to
45 °C and set to stir for 24 h. The solution was then allowed to
cool and acetone was added to precipitate out a yellow solid
which was filtered, washed with acetone and dried. This solid
(0.018 g, 0.025 mmol) was dissolved in the minimum amount
of DMSO and to this an aqueous solution of NaPF6 was added.
This resulted in an orange precipitate which was filtered,
washed with diethyl ether and dried. The product was
obtained as a yellow solid (0.023, 73%); 1H NMR (400 MHz,
DMSO-d6): δH 9.02 (d, 2H,
3JHH = 8.0, tpy 2-H), 8.72 (d, 2H,
3JHH = 8.0, tpy 5-H), 8.57 (dd, 2H,
3JHH = 8.0, 8.0, tpy 4-H), 8.35
(s, 2H, tpy′ 3-H and 5-H), 8.01 (dd, 2H, 3JHH = 8.0, 8.0, py 3-H),
4.57 (t, 2H, 3JHH = 8.0, propyl 3-H), 3.84 (t, 2H,
3JHH = 8.0,
propyl 1-H), 3.58–2.86 (br m, 16H, cyclen), 2.38 (m, 2H, propyl
2-H); 31P NMR(400 MHz, DMSO-d6): δP −143.95 (sep); IR
(cm−1): 1570, 1442, 1405, 1334, 1219, 998, 827; UV/Vis (DMSO)
λmax/nm (ε/cm
−1 M−1): 320 (7700), 334 (8120); ESI-MS Calcd for
C26H38ClF6N7OP4Pt [M]
+: 1275 a.m.u., Found [M]+: 838 a.m.u.,
[M − 2H − 3PF6]+: 838 a.m.u.; Anal. Calcd for
C26H38ClF24N7OP4Pt·2H2O: C 23.82, H 3.23, N 7.48; Found: C
23.60, H 2.71, N 7.03.
Synthesis of 11. L4 (0.020 g, 0.043 mmol) was dissolved in
dimethyl sulphoxide (2 mL) and added to a solution of K2PtCl4
(0.019 mg, 0.047 mmol) in dimethyl sulphoxide (2 mL). The
solution was heated to 45 °C and set to stir for 24 h. To the
resultant orange solution 1.1 eq. of ZnCl2 (0.0064 g,
0.047 mmol) was added and the solution stirred for a further
24 h at 45 °C. An aqueous solution of NaPF6 was added directly
to the reaction mixture which yielded a yellow precipitate,
which was filtered, washed with diethyl ether and dried. The
product was isolated as a yellow PF6 salt (0.026 g, 51%);
1H NMR (400 MHz, DMSO-d6): δH 9.01 (d, 2H,
3JHH = 8.0, tpy 2-
H), 8.70 (d, 2H, 3JHH = 8.0, tpy 5-H), 8.56 (dd, 2H,
3JHH = 8.0,
tpy 4-H), 8.33 (s, 2H, tpy′ 3-H and 5-H), 8.01 (dd, 2H, 3JHH =
8.0, 8.0, py 3-H), 4.55 (t, 2H, 3JHH = 4.0, propyl 3-H), 3.83 (t, 2H,
3JHH = 8.0, propyl 1-H), 3.60–2.80 (br m, 16H, cyclen), 2.37 (m,
2H, propyl 2-H); COSY 1H–1H NMR (400 MHz, DMSO-d6): see
appendix; 13C NMR (400 MHz, DMSO-d6): δC 176.8, 168.9,
158.2, 155.6, 151.0, 142.2, 129.4, 125.5, 110.9, 68.0, 60.6, 54.7
53.0, 52.3, 50.6, 26.5; 31P NMR(400 MHz, DMSO-d6):
δp −144.40 (sep); IR (cm−1): 1610, 1475, 1429, 1363, 1220,1034,
826, 779, 739; UV/Vis (DMSO) λmax/nm (ε/cm
−1 M−1): 319
(9380), 334 (9480); ESI-MS Calcd for C26H35ClF18N7OP3PtZn
[M]+: 1193 a.m.u. Found [M − 2PF6 + K]+: 940 a.m.u.; Anal.
Calcd For C26H35ClF18N7OP3PtZn·4.8H2O: C, 24.42; H, 3.52; Cl,
2.77; N, 7.67; Found: C 24.97, H 3.05, N 7.17.
Synthesis of 12. L4 (0.020 g, 0.043 mmol) was dissolved in
dimethyl sulphoxide (2 mL) and added to a solution of K2PtCl4
(0.019 mg, 0.047 mmol) in dimethyl sulphoxide (2 mL). The
solution was heated to 45 °C and set to stir for 24 h. To the
resultant orange solution 1.1 eq. of CuCl2·2H2O (0.0080 g,
0.047 mmol) was added and the solution stirred for a further
24 h at 45 °C. During this time the colour of the solution
turned from yellow to a pale green. An aqueous solution of
NaPF6 was added directly to the reaction mixture which
yielded a green precipitate, which was filtered, washed with
diethyl ether and dried. The product was isolated as a pale
green PF6 salt (0.031 g, 61%); IR (cm
−1): 1621, 1428, 1205,
1035, 831, 779, 741; UV/Vis (DMSO) λmax/nm (ε/cm
−1 M−1): 319
(11 500), 334 (12 240); ESI-MS Calcd for C26H35ClCuF18N7OP3Pt
[M]+: 1189 a.m.u. Found [M − PF6]+: 1450 a.m.u.; Anal. Calcd
For C26H35ClCuF18N7OP3Pt·4H2O·NaCl: C, 23.64; H, 3.28; N,
7.42; Found: C 23.45, H 2.83, N 7.04.
Synthesis of 14. Compound 13 (25 mg, 0.048 mmol) and L5
(35 mg, 0.240 mmol) were stirred in water (5 ml) at 40 °C for
48 h to aﬀord an orange solution. After removing excess thiol
by extraction with diethyl ether (10 ml × 3) the aqueous layer
was removed under reduced pressure. The resultant solid was
dissolved in the minimum amount of DMSO, to which excess
NaPF6 (as an aqueous solution) was added dropwise. This
yielded a purple precipitate which was isolated by filtration
and washed repeatedly with water and diethyl ether. The
mono-arm complex was isolated as an purple powder (28 mg,
66%); 1H NMR (400 MHz, DMSO-d6): δH 9.39 (d, 1H,
3JHH =
8.0, phen 2-H), 9.35 (d, 1H, 3JHH = 4.0, pyridyl 2-H), 9.22 (d,
1H, 3JHH = 8.0, phen 9-H), 9.10 (d, 1H,
3JHH = 8.0, phen 4-H),
8.94 (d, 1H, 3JHH = 8.0, phen 10-H), 8.80 (d, 1H,
3JHH = 4.0,
pyridyl 5-H), 8.59 (t, 1H, 3JHH = 8.0, phen 3-H), 8.38 (dd, 2H,
3JHH = 8.0, phen 6-H and 7-H), 8.27 (dd, 1H,
3JHH = 8.0, 4.0,
pyridyl 3-H), 8.05 (t, 1H, 3JHH = 8.0, pyridyl 4-H), 2.92 (m, 2H,
ethyl 1-H), 2.81 (m, 2H, ethyl 2-H), 2.67 (m, 1H, pip N+–H),
1.74 (m, H, pip 1-H), 1.59 (m, 6H, pip 2-H and 3-H); 31P NMR
(400 MHz, DMSO-d6): δP −144.8 (sept, 2P, 1JP–F = 1756, PF6);
ESI-MS Calcd for C24H25F12N4P2PtS[M]
+: 886.6 a.m.u. Found
[M + 3H+ − 2PF6]+: 623.0 a.m.u.; Anal. Calcd for
C24H25F12N4P2PtS·2HCl: C 30.04, H 2.84, N 5.84; Found: C
29.52, H 2.83, N 5.21.
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Synthesis of 15. Ligand L8 (50 mg, 0.13 mmol) and
[PtCl2(COD)] (49 mg, 0.13 mmol) were placed in water (7 ml)
and stirred at 75 °C for 3 h. During this time the reactants
completely dissolved giving a yellow solution. Upon cooling
the reaction mixture a saturated aqueous solution of NaPF6
was added to give the product as an orange solid. The solid
was filtered and washed thoroughly with water (10 ml) and
diethyl ether (10 ml). The mono-arm complex was isolated as a
orange powder (15 mg, 13%); 1H NMR (400 MHz, DMSO-d6):
δH 9.18 (d, 1H,
3JHH = 8.0, phen 2-H), 8.76 (m, 4H, pyridyl 2-H,
phen 4-H, 9-H and 10-H), 8.70 (d, 1H, 3JHH = 8.0, pyridyl 5-H),
8.56 (t, 1H, 3JHH = 8.0, phen 3-H), 8.04 (t, 1H,
3JHH = 8.0,
pyridyl 3-H), 7.98 (t, 1H, 3JHH = 8.0, pyridyl 4-H), 7.70 (s, 1H,
phen 7-H), 4.73 (br s, 3H, ethyl 1-H and pip N+–H), 3.71 (br s,
2H, ethyl 2-H), 3.31 (m, 4H, pip 1-H), 1.81 (m, 4H, pip 2-H),
1.58 (m, 2H, pip 3-H); 31P NMR (400 MHz, DMSO-d6): δP
−144.2 (sept, 2P, 1JP–F = 1756, PF6); ESI-MS Calcd for
C24H25ClF12N4OP2Pt [M]
+: 905.0 a.m.u. Found [M − PF6]+:
759.0 a.m.u., [M − 2PF6]+: 615.0 a.m.u.; Anal. Calcd for
C24H25ClF12N4OP2Pt: C 31.82, H 2.78, N 6.18; Found: C 31.24,
H 2.97, N 5.32.
X-ray crystallography
Crystal data for 5. [C22H26N4PtS](Cl)2·2MeOH, M = 708.60,
triclinic, P1ˉ (no. 2), a = 7.46100(15), b = 13.0861(3), c = 14.1346
(3) Å, α = 85.6977(18), β = 80.5574(17), γ = 82.6405(18)°, V =
1348.07(5) Å3, Z = 2, Dc = 1.746 g cm
−3, μ(Cu-Kα) =
12.511 mm−1, T = 173 K, red needles, Oxford Diﬀraction Xcali-
bur PX Ultra diﬀractometer; 5329 independent measured
reflections (Rint = 0.0306), F
2 refinement,57–59 R1(obs) = 0.0295,
wR2(all) = 0.0748, 4924 independent observed absorption-
corrected reflections [|Fo| > 4σ(|Fo|), 2θmax = 145°], 337 para-
meters. CCDC 1023715.
Crystal data for 8. [C26H35Cl3N7OZn2](ZnCl4)0.5·0.5
(Me2CO)·2H2O, M = 867.36, triclinic, P1ˉ (no. 2), a = 14.9174(4),
b = 15.4884(5), c = 18.5245(5) Å, α = 69.026(3), β = 81.075(2), γ =
63.677(3)°, V = 3582.0(2) Å3, Z = 4 (two independent mole-
cules), Dc = 1.608 g cm
−3, μ(Cu-Kα) = 5.773 mm−1, T = 173 K,
colourless needles, Oxford Diﬀraction Xcalibur PX Ultra diﬀr-
actometer; 13 810 independent measured reflections (Rint =
0.0342), F2 refinement,57–59 R1(obs) = 0.0378, wR2(all) = 0.1087,
11772 independent observed absorption-corrected reflections
[|Fo| > 4σ(|Fo|), 2θmax = 145°], 876 parameters. CCDC 1023716.
Crystal data for 9. [C26H35Cu2Cl3N7O](Cl)·6.5H2O, M =
847.59, monoclinic, C2/c (no. 15), a = 38.832(4), b = 14.0405(8),
c = 13.7761(10) Å, β = 101.090(9)°, V = 7370.8(10) Å3, Z = 8, Dc =
1.528 g cm−3, μ(Cu-Kα) = 4.532 mm−1, T = 173 K, blue platy
needles, Oxford Diﬀraction Xcalibur PX Ultra diﬀractometer;
7202 independent measured reflections (Rint = 0.0735),
F2 refinement,57–59 R1(obs) = 0.0779, wR2(all) = 0.2702, 4286
independent observed absorption-corrected reflections [|Fo| >
4σ(|Fo|), 2θmax = 145°], 431 parameters. CCDC 1023717.
Fluorescent intercalator displacement (FID) assay
The FID assay was performed on a Varian Cary Eclipse spectro-
meter following a reported procedure.31,36 The 22AG strand
(5′-AGG-GTT-AGG-GTT-AGG-GTT-AGG-G-3′) and 20AG strand
(5′-GG-GAG-GGT-GGG-GAG-GGT-GGG-3′) were used for the
human telomeric and c-Myc studies, respectively. For the
duplex DNA studies, a 26 base pair self-complimentary strand
(5′-CAA-TCG-GAT-CGA-ATT-CGA-TCC-GAT-TG-3′) was used.
UV-VIS titration procedure
The UV-Vis spectra were recorded on a Perkin Elmer Lambda
25 spectrometer. In order to determine the binding constants
of the selected complexes with c-Myc, Htelo and ct-DNA, the
complexes (50 µM) were titrated with concentrated solutions of
DNA (c-Myc: 1.40 mM, Htelo: 2.50 mM and ct-DNA: 4.56 mM)
in 50 mM Tris-HCl (pH 7.4)/100 mM KCl buﬀer. A 1 cm path-
length quartz cuvette was used to carry out the measurements.
The binding constants were obtained by fitting the data to a
reciprocal plot of D/Δεap versus D using the following equation:
D/Δεap = D/Δε + 1/(Δε × K) where the concentration of DNA is
expressed in terms of base pairs (determined by measuring
the absorption at 260 nm and the appropriate extinction coeﬃ-
cients), the apparent molar extinction coeﬃcient εa = Aobserved/
[complex], Δεap = [εa − εf ] and Δε = [εb − εf ]. εb is the extinction
coeﬃcient of the DNA bound complex and εf is the extinction
coeﬃcient of the free complex.
Cellular studies – general procedures
The U2OS human osteosarcoma and GM05757 normal human
fibroblast cell lines were obtained from the London Research
Institute, Cancer Research UK. The cells were maintained in
Dulbecco’s Modified Eagle’s Medium (DMEM-low glucose)
media which was supplemented with 10% fetal bovine serum
and 1% penicillin/streptomycin. All cells were grown at 310 K
in a humidified atmosphere containing 5% CO2.
MTS cytotoxicity assays
Cells (5 × 104 for U2OS and 1 × 104 for GM05757) were seeded
in each well of a 96-well plate. After 24 h the cells were exposed
to various concentrations of the test compound (0–500 µM) for
a further 24 h (total volume 100 µL). The test compounds were
prepared as 10 mM solutions in DMSO and diluted further
using DMSO. The final concentration of DMSO in each well
was 4%. After the incubation period, 20 µL of the MTS solution
(made up of 2 mg mL−1 MTS reagent + 100 µL of PMS 0.96 mg
mL−1) was added to each well. The mixture was incubated for a
further 1.5 h at 37 °C. After this time, the absorption at
490 nm was recorded and the EC50 values were determined
using the Conventional Method (“Refinement in the Use and
Data Analysis of the Promega CellTiter 96® AQueous Non-
Radioactive Cell Proliferation Assay” by A. Zarei and
B. Markovic, Promega Corporation, 2000). EC50 values were cal-
culated from the following equation: Abs EC50 = (Abs EC0 +
Abs EC100)/2; where EC0 is the mean absorption at 490 nm of
the media only and EC100 is the mean absorption at 490 nm of
the cells only (with 4% DMSO). Then the x-axis intercept of the
dose–response curve at Abs EC50 (determined by the above
equation) was considered as the EC50 value for each test com-
pound. The dose–response curve plot the concentration of test
Paper Dalton Transactions
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compound exposed to the cells (x-axis) against absorption at
490 nm (y-axis). Prior to plotting the curve the background
absorption (due to the reaction of the test compound and MTS
reagents) was subtracted from the absorption values obtained
from the cells that had been incubated with the compounds.
Cellular uptake protocol
To measure the cellular uptake of the metal complexes, ca.
2 million U2OS cells were treated with 10 µM of the corres-
ponding compound at 37 °C for 24 h. Then the media was
removed, the cells were washed with PBS solution (×3),
harvested from adherent cultures by trypsinization and centri-
fuged (1000g for 5 min). The cellular pellet was suspended in
an appropriate volume of PBS to obtain a homogeneous cell
suspension. The suspension was divided in two. One part was
used to analyse the metal content in the whole cell and the
other was used for the cytoplasmic and nucleus analysis. The
Thermo Scientific NE-PER Nuclear and Cytoplasmic Extraction
Kit was used to extract the separate cytoplasmic and nuclear
protein fractions. From each of the fraction aliquots were
removed for protein determination using the Bradford Assay
(carried according to the instructions of the manufacturer –
Sigma Aldrich, micro-well plate protocol). The remaining cell
suspension was mineralized with 65% HNO3 and then comple-
tely dried at 120 °C. The solid extracts were re-dissolved in 2%
HNO3 and analysed using ICP-MS. Cellular metal levels were
expressed as ng metal/mg protein. Results are presented as the
mean of 7 determinations for each data point ± standard devi-
ation obtained in three separate experiments. The fraction of
the administered complexes that were taken up by the cells
was calculated by dividing the amount of complex detected in
the whole cell, cytoplasm and nucleus (i.e. the raw measure-
ment in ng) by the total mass of metal corresponding to the
concentration administered for each complex (10 µM con-
verted to ng). The fractions were normalised so that all treated
cells were accounted. The percentage of the administered com-
plexes that were taken up by the cells was then determined by
timing the normalised fractions by 100.
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